1. Home
  2. GKOS vs FAF Comparison

GKOS vs FAF Comparison

Compare GKOS & FAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

N/A

Current Price

$97.97

Market Cap

6.9B

Sector

Health Care

ML Signal

N/A

Logo First American Corporation (New)

FAF

First American Corporation (New)

N/A

Current Price

$63.08

Market Cap

6.3B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
GKOS
FAF
Founded
1998
1889
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Specialty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
6.9B
6.3B
IPO Year
2015
2009

Fundamental Metrics

Financial Performance
Metric
GKOS
FAF
Price
$97.97
$63.08
Analyst Decision
Strong Buy
Buy
Analyst Count
14
4
Target Price
$133.07
$78.50
AVG Volume (30 Days)
679.7K
972.1K
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
3.46%
EPS Growth
N/A
376.19
EPS
N/A
6.00
Revenue
$507,442,000.00
$7,452,200,000.00
Revenue This Year
$23.39
$8.04
Revenue Next Year
$27.46
$5.60
P/E Ratio
N/A
$10.59
Revenue Growth
32.33
21.61
52 Week Low
$73.16
$53.95
52 Week High
$130.23
$71.47

Technical Indicators

Market Signals
Indicator
GKOS
FAF
Relative Strength Index (RSI) 29.36 36.32
Support Level $81.54 $61.26
Resistance Level $102.19 $66.10
Average True Range (ATR) 3.58 1.82
MACD -2.20 -0.78
Stochastic Oscillator 0.38 6.58

Price Performance

Historical Comparison
GKOS
FAF

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About FAF First American Corporation (New)

First American Financial Corp is a financial services business providing insurance through segments: Title insurance and related services segment include real estate insurance, property closing services, third-party handling of real estate funds (escrow), risk mitigation, real estate data products, and related real estate transaction services; The home warranty segment provides residential service contracts that cover residential systems, such as heating and air conditioning systems, and certain appliances against failures that occur as the result of normal usage during the coverage period; and The corporate segment includes investments in venture-stage companies, certain financing facilities and corporate services supporting the company's business operations.

Share on Social Networks: